In a report shared with Science in October 2023, a committee investigating allegations of misconduct by Dr. Hoau-Yan Wang, a professor at the City College of New York (CCNY, which falls under the City University of New York (CUNY)), found evidence that was ‘highly suggestive of deliberate scientific misconduct’. Dr. Wang has been a frequent collaborator with Cassava Sciences (Nasdaq: SAVA), a biotech company working on a drug called simufilam for the treatment of Alzheimer’s disease. Unfortunately, Dr. Wang was unable to provide the committee with any original data or notebooks that could have addressed concerns about his work. Although the suspicions of manipulated images could therefore not be proved, the investigation revealed “long-standing and egregious misconduct in data management and record keeping by Dr. Wang”.
Science Integrity Digest 